Pregnancy outcome of a patient with atypical polypoid adenomyoma

Wong, Alice Yuen Kwan; Chan, Kit-sheung; Lau, WL; Tang, L.

doi:10.1016/j.fertnstert.2007.01.043

Cited by 18 publications

(23 citation statements)

References 8 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…They suggested similar infertility treatment consisting of progestin therapy, repeated curettage, and ovulation induction. Wong et al reported that a patient with persistent APA had pregnancy twice with the use of Danggui ( Angelica sinensis ), a traditional Chinese medicine herb that regulates menstrual cycles and corrects amenorrhea.…”

Section: Discussionmentioning

confidence: 99%

Pregnant outcomes of atypical polypoid adenomyoma treated with progestin therapy

Chen

Lü

2017

J of Obstet and Gynaecol

View full text Add to dashboard Cite

show abstract

Section: Discussionmentioning

confidence: 99%

Pregnant outcomes of atypical polypoid adenomyoma treated with progestin therapy

Chen

Lü

2017

J of Obstet and Gynaecol

View full text Add to dashboard Cite

show abstract

“…Nasu et al suggested that estrogen-related factors play a key role in the pathogenesis of APA [16]. Some other authors reported detection of occult APA during an infertility work-up [10,11]. It is unclear whether APA is the cause of infertility, whether an endocrine environment that causes infertility also causes APA, or whether the two situations can coexist.…”

Section: Discussionmentioning

confidence: 99%

“…Wong et al reported that a patient with APA, who was free from the disease during pregnancy, experienced recurrence after the child birth. Those authors hypothesized that the high progesterone level during pregnancy plays a protective role [11].…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Long-term outcomes of fertility-sparing treatment of atypical polypoid adenomyoma with medroxyprogesterone acetate

Nomura

Sugiyama

Tanigawa

et al. 2015

Arch Gynecol Obstet

View full text Add to dashboard Cite

show abstract

“…Obesity (1), prolonged estrogenic stimulation (9), and infertility (10,11) are among the causes of the disease. Although APA has been mainly treated surgically, it may not be a rational treatment option.…”

Section: Introductionmentioning

confidence: 99%

Maintenance hormonal therapy after treatment with medroxyprogesterone acetate for patients with atypical polypoid adenomyoma

Nomura

Sugiyama

Tanigawa

et al. 2018

Japanese Journal of Clinical Oncology

View full text Add to dashboard Cite

Background: As atypical polypoid adenomyoma (APA) has been reported to be a hormone-related tumor, we aimed to analyze the efficacy and safety of maintenance hormonal therapy after fertility-preserving treatment of these patients with medroxyprogesterone acetate (MPA). Methods: Data were retrospectively analyzed from patients with APA who were treated with a fertility-preserving regimen including MPA between October 2001 and December 2011. Eighteen patients were treated with MPA and 14 (77.8%) achieved either a complete or a partial response after the planned treatment. Five patients took progestin for maintenance therapy. Results: Eighteen patients were treated for a mean observation period of 96.7 months. While taking the maintenance therapy, no patient had APA relapse. One patient developed welldifferentiated endometrioid adenocarcinoma 18 months after she stopped taking maintenance progestin. Eleven patients without maintenance therapy underwent hysterectomy, andnine of them developed well-differentiated endometrial cancer. Through univariate analysis, there was a significant difference in time to hysterectomy between patients with and without maintenance therapy (P = 0.015). Through multivariate analysis, body mass index (BMI), menstrual status before protocol therapy, maintenance treatment, and pregnancy were found to be significantly associated with a lower risk of hysterectomy. No patient had a recurrence of APA after hysterectomy during the observation period (median, 54 months; range, 2-148 months). Conclusion: No patient showed progression while receiving hormonal therapy, including initial protocol therapy. Maintenance hormonal therapy after treatment with MPA was highly effective and safe, particularly in patients with BMI ≧24 kg/m 2 and irregular menstruation cycle.

show abstract

Pregnancy outcome of a patient with atypical polypoid adenomyoma

Cited by 18 publications

References 8 publications

Pregnant outcomes of atypical polypoid adenomyoma treated with progestin therapy

Pregnant outcomes of atypical polypoid adenomyoma treated with progestin therapy

Long-term outcomes of fertility-sparing treatment of atypical polypoid adenomyoma with medroxyprogesterone acetate

Maintenance hormonal therapy after treatment with medroxyprogesterone acetate for patients with atypical polypoid adenomyoma

Contact Info

Product

Resources

About